The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent.
Devy L, Blacher S, Grignet-Debrus C, Bajou K, Masson V, Gerard RD, Gils A, Carmeliet G, Carmeliet P, Declerck PJ, Nöel A, Foidart JM.
Devy L, et al. Among authors: foidart jm.
FASEB J. 2002 Feb;16(2):147-54. doi: 10.1096/fj.01-0552com.
FASEB J. 2002.
PMID: 11818362